US approves AstraZeneca asthma drug for COPD – Reuters
 SYS-CON Media | US approves AstraZeneca asthma drug for COPD Reuters N) asthma drug Symbicort to also treat patients with the lung disorder known as COPD, or chronic obstructive pulmonary disease, the company said on Friday. The drug aims to help improve lung function and help manage symptoms over time but is not ... FDA Approves Budesonide/Formoterol Fumarate Dihydrate for COPD DG News FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary ... PR Newswire (press release) AstraZeneca reveals FDA Approval For SYMBICORT - Update RTT News Forbes - RTT News all 27 news articles |